X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
89
PharmaCompass offers a list of Moxifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Moxifloxacin manufacturer or Moxifloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Moxifloxacin manufacturer or Moxifloxacin supplier.
PharmaCompass also assists you with knowing the Moxifloxacin API Price utilized in the formulation of products. Moxifloxacin API Price is not always fixed or binding as the Moxifloxacin Price is obtained through a variety of data sources. The Moxifloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Moxifloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moxifloxacin, including repackagers and relabelers. The FDA regulates Moxifloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moxifloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Moxifloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Moxifloxacin supplier is an individual or a company that provides Moxifloxacin active pharmaceutical ingredient (API) or Moxifloxacin finished formulations upon request. The Moxifloxacin suppliers may include Moxifloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Moxifloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Moxifloxacin Drug Master File in Korea (Moxifloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Moxifloxacin. The MFDS reviews the Moxifloxacin KDMF as part of the drug registration process and uses the information provided in the Moxifloxacin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Moxifloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Moxifloxacin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Moxifloxacin suppliers with KDMF on PharmaCompass.
A Moxifloxacin written confirmation (Moxifloxacin WC) is an official document issued by a regulatory agency to a Moxifloxacin manufacturer, verifying that the manufacturing facility of a Moxifloxacin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Moxifloxacin APIs or Moxifloxacin finished pharmaceutical products to another nation, regulatory agencies frequently require a Moxifloxacin WC (written confirmation) as part of the regulatory process.
click here to find a list of Moxifloxacin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Moxifloxacin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Moxifloxacin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Moxifloxacin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Moxifloxacin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Moxifloxacin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Moxifloxacin suppliers with NDC on PharmaCompass.
Moxifloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Moxifloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Moxifloxacin GMP manufacturer or Moxifloxacin GMP API supplier for your needs.
A Moxifloxacin CoA (Certificate of Analysis) is a formal document that attests to Moxifloxacin's compliance with Moxifloxacin specifications and serves as a tool for batch-level quality control.
Moxifloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Moxifloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Moxifloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Moxifloxacin EP), Moxifloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Moxifloxacin USP).
Market Place
